Century Therapeutics (IPSC) director reports zero beneficial share ownership

Rhea-AI Filing Summary

Century Therapeutics, Inc. disclosed that one of its directors submitted an initial insider ownership statement indicating no beneficial ownership of company securities. The report shows no direct or indirect holdings of common stock or derivative securities, so the director reported zero beneficial ownership as of the event date of 12/09/2025.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lee Han Myung

(Last) (First) (Middle)

25 N 38TH ST.

11TH FLOOR

(Street)

PHILADELPHIA PA 19104

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/09/2025

3. Issuer Name and Ticker or Trading Symbol
Century Therapeutics, Inc. [ IPSC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Douglas Carr, Attorney-in-Fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Century Therapeutics (IPSC) director disclose about share ownership?

The director reported no beneficial ownership of Century Therapeutics, Inc. securities, meaning no shares or other securities of the company were listed as owned.

Does the Century Therapeutics (IPSC) director hold any derivative securities?

No. The insider ownership statement indicates no derivative securities, such as options, warrants, or convertible instruments, are beneficially owned.

What does it mean when a Century Therapeutics (IPSC) insider reports no securities beneficially owned?

It means the insider has no economic or voting interest in Century Therapeutics, Inc. securities that must be reported under insider ownership rules.

Is this Century Therapeutics (IPSC) insider report filed individually or jointly?

The statement is marked as filed by one reporting person, indicating it covers a single director rather than a group filing.

What is the event date for this Century Therapeutics (IPSC) insider ownership report?

The date of the event requiring the insider ownership statement is listed as 12/09/2025.